VII.2.11 Recurrence Information

Recurrence occurs when a patient's primary tumor persisted after a period of complete remission. The following fields must be coded by American College of Surgeons-approved registries. The data items are optional for reporting to the California Cancer Registry.

Date of First Recurrence
Type of First Recurrence

Coding Instructions:

Code only the first recurrence and do not update the fields except to correct data entry errors.

Enter the date of first recurrence of a primary tumor that recurred after a period of complete remission. See Sections I.1.6.3 and I.1.6.4 for Coding and Entering Dates.

If the exact date is not known, enter an estimate based on the best available information.

If the patient was never free of the primary tumor or did not experience a recurrence, leave the field as zeros.

The Distant Recurrence Sites field has been removed and incorporated into the Type of First Recurrence field.

Codes:

Code

Description

None, disease free.

In situ.

Recurrence following diagnosis of an in situ lesion of the same site.

Local.

Trocar site.

Combination of 10 and 11.

Local recurrence following an in situ lesion of the same site.

Combination of 16 with 10, 11 and/or 15.

Regional, NOS.

Regional tissue.

Regional lymph nodes.

Combination of 21 and 22.

Regional recurrence following an in situ lesion of the same site.

Combination of 26 with 21, 22, and/or 25.

Any combination of 10, 11, and 20, 21 or 22.

Any combination of recurrence following an in situ lesion of the same site with 10, 11, 20, 21 or 22.

Distant recurrence, and there is insufficient information available to code to 46-62.

Distant recurrence of an in situ tumor.

Distant recurrence of invasive tumor in the peritoneum only. Peritoneum includes peritoneal surfaces of all structures within the abdominal cavity and/or positive ascitic fluid.

Distant recurrence of an invasive tumor in the lung only. Lung includes the visceral pleura.

Distant recurrence of an invasive tumor in the pleura only. Pleura includes the pleural surface of all structures within the thoracic cavity and/or positive pleural fluid.

Distant recurrence of an invasive tumor in the liver only.

Distant recurrence of an invasive tumor in bone only. This includes bones other than the primary site.

Distant recurrence of an invasive tumor in the CNS only. This includes the brain and spinal cord, but not the external eye.

Distant recurrence of an invasive tumor in the skin only. This includes skin other than the primary site.

Distant recurrence of an invasive tumor in lymph node only. Refer to the staging scheme for a description of lymph nodes that are distant for a particular site.

Distant systemic recurrence of an invasive tumor only. This includes leukemia, bone marrow metastasis, carcinomatosis, generalized disease.

Distant recurrence of an invasive tumor in a single distant site (51-58) and local, trocar and/or regional recurrence (10-15, 20-25, or 30).

Distant recurrence of an invasive tumor in multiple sites (recurrences that can be coded to more than one category 51-59).

Since diagnosis, patient has never been disease-free. This includes cases with distant metastasis at diagnosis, systemic disease, unknown primary, or minimal disease that is not treated.

Disease has recurred, but the type of recurrence is unknown.

It is unknown whether the disease has recurred or if the patient was ever disease-free.